Extensive Labeling Required Under Device Remarketers' Voluntary System
This article was originally published in The Gray Sheet
Device remarketers and servicers should indicate whether reserviced devices are "ready for clinical use" or "must be checked for proper performance and safety" under a proposed voluntary registration system issued Sept. 9 by an industry task force coordinated by the Association for the Advancement of Medical Instrumentation.
You may also be interested in...
Device remarketers that label serviced devices as "ready for clinical use" under a recently proposed voluntary registration system will be subject to FDA enforcement action if the devices do not meet performance specifications, according to FDA staffers.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.